Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
十五味沉香丸 (Shiwuwei Chenxiang Wan) is a traditional Tibetan medicine (TTM) manufactured by Xizang Ganlu Tibetan Medicine. It is an approved pharmaceutical product in China, identified by the National Drug License Number Z54020051. Formulated as an oral pill, it is primarily used to treat disorders classified under 'Lung' (wind) in Tibetan medicine, which correspond to cardiovascular and psychosomatic conditions. Its clinical indications include coronary heart disease, angina pectoris, heart palpitations, shortness of breath, and neurasthenia. The preparation consists of fifteen herbal and mineral ingredients, with Agarwood (*Aquilaria sinensis*) acting as the principal component to soothe the nerves and regulate vital energy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 十五味沉香丸.